Eligibility Criteria: Subjects must have a diagnosis of stage I or IIA (cutaneous only) Mycosis Fungoides. He/she must have tried other topical treatments like steroids or phototherapy, but must stop all treatments before being enrolled. If female, you cannot be pregnant or breastfeeding. Other restrictions will be explained at the screening visit.
Institution: Brigham and Women's Hospital
Principal Investigator: Alexandra B. Kimball, MD, MPH
Enrollment Information: For further information please contact Lynne Hermosilla
at (617) 726-5066 or e-mail harvardskinstudies@partners.org.